English version
Lars Håkon Reiestad Tanum

Lars Håkon Reiestad Tanum

Fagområder

Vitenskapsdisipliner

Klinisk farmakologi   Epidemiologi medisinsk og odontologisk statistikk   Samfunnsmedisin, sosialmedisin   Farmakologi

Forskningsgrupper

Vitenskapelige publikasjoner

Brenna, Ida Halvorsen; Waleur, Karin Merethe ; Saltyte Benth, Jurate; Solli, Kristin Klemmetsby; Mordal, Jon; Løberg, Else-Marie; Weimand, Bente ; Tanum, Lars Håkon Reiestad (2024). Patients with Opioid Use Disorder Choosing Treatment with Extended-Release Naltrexone: A 6-Month Naturalistic Study. 12 s. European Addiction Research.
https://doi.org/10.1159/000541431

Marciuch, Anne; Birkeland, Bente; Saltyte Benth, Jurate; Solli, Kristin Klemmetsby; Tanum, Lars Håkon Reiestad ; Mathisen, Ida; Weimand, Bente (2023). Personal recovery among people with opioid use disorder during treatment with extended-release naltrexone. 12 s. Heliyon. Vol. 9.
https://doi.org/10.1016/j.heliyon.2023.e17516

Weimand, Bente Margrethe ; Karlsson, Ann Tarja; Solli, Kristin Klemmetsby; Vederhus, John-Kåre; Mordal, Jon; Digranes, Linn Camilla Wergeland; Tanum, Lars Håkon Reiestad (2023). Characteristics of opioid-dependent patients choosing antagonist treatment with extended-release naltrexone compared with patients in opioid maintenance treatment in Norway. 9 s. Heroin Addiction and Related Clinical Problems. Vol. 25.

Midgard, Håvard; Malme, Kristian Braathen; Phil, Charlotte Meinich; Berg-Pedersen, Riikka Mari; Tanum, Lars Håkon Reiestad ; Klundby, Ingvild; Haug, Anne; Tveter, Ida Giæver; Bjørnestad, Ronny; Olsen, Inge Christoffer; Finbråten, Ane-Kristine; Dalgard, Olav (2023). Opportunistic Treatment of Hepatitis C Infection Among Hospitalized People Who Inject Drugs (OPPORTUNI-C): A Stepped Wedge Cluster Randomized Trial. 8 s. Clinical Infectious Diseases. Vol. 78.
https://doi.org/10.1093/cid/ciad711

Opheim, Arild; Saltyte Benth, Jurate; Solli, Kristin Klemmetsby; Kloster, Pia Synnøve; Fadnes, Lars T.; Kunøe, Nikolaj; Gaulen, Zhanna; Tanum, Lars Håkon Reiestad (2023). Risk of relapse to non-opioid addictive substances among opioid dependent patients treated with an opioid receptor antagonist or a partial agonist: A randomized clinical trial. 9 s. Contemporary Clinical Trials. Vol. 135.
https://doi.org/10.1016/j.cct.2023.107360

Broekhof, Rosalie; Nordahl, Hans Morten; Tanum, Lars Håkon Reiestad ; Selvik, Sara Germans (2023). Adverse childhood experiences and their association with substance use disorders in adulthood: A general population study (Young-HUNT). 8 s. Addictive Behaviors Reports. Vol. 17.
https://doi.org/10.1016/j.abrep.2023.100488

Karlsson, Ann Tarja; Vederhus, John-Kåre; Clausen, Thomas; Weimand, Bente Margrethe ; Solli, Kristin Klemmetsby; Tanum, Lars Håkon Reiestad (2022). Impact of Impulsivity, Hyperactivity, and Inattention on Discontinuation Rate among Opioid-Dependent Patients Treated with Extended-Release Naltrexone. 7 s. International Journal of Environmental Research and Public Health (IJERPH). Vol. 19.
https://doi.org/10.3390/ijerph191811435

Marciuch, Anne; Brenna, Ida Halvorsen; Weimand, Bente ; Solli, Kristin Klemmetsby; Tanum, Lars Håkon Reiestad ; Røstad, Bente; Birkeland, Bente (2022). Patients’ experiences of continued treatment with extended-release naltrexone: a Norwegian qualitative study. 14 s. Addiction science & clinical practice. Vol. 17.
https://doi.org/10.1186/s13722-022-00317-2

Brenna, Ida Halvorsen; Marciuch, Anne; Birkeland, Bente; Veseth, Marius; Røstad, Bente; Løberg, Else-Marie; Solli, Kristin Klemmetsby; Tanum, Lars Håkon Reiestad ; Weimand, Bente (2021). ‘Not at all what I had expected’: Discontinuing treatment with extended-release naltrexone (XR-NTX): A qualitative study. Journal of Substance Abuse Treatment.
https://doi.org/10.1016/j.jsat.2021.108667

Karlsson, Ann Tarja; Vederhus, John-Kåre; Clausen, Thomas; Weimand, Bente ; Solli, Kristin Klemmetsby; Tanum, Lars Håkon Reiestad (2021). Levels of impulsivity, hyperactivity, and inattention and the association with mental health and substance use severity in opioid-dependent patients seeking treatment with extended-release naltrexone. 8 s. Journal of Clinical Medicine. Vol. 10.
https://doi.org/10.3390/jcm10194558





Publikasjonslisten er hentet ut av Cristin. Listen kan være ufullstendig